Zimmer Biomet's Q3 Sales Growth and CEO Tornos' Vision for Innovation

Zimmer Biomet Sees Steady Q3 Sales Growth, New CEO Tornos Unveils Vision for an ‘Innovation Journey’

Anika Sharma

Zimmer Biomet’s executive branch experienced significant changes in the third quarter, but these transitions haven’t derailed the company’s steady growth ...

humira, biosimilars, sales, switching, spherix, physicians, market share

Humira sales decline as biosimilars gain traction, but physicians remain wary of switching patients

Anika Sharma

In the race to capture a share of the $20 billion annual revenue generated by AbbVie’s blockbuster biologic, Humira biosimilars ...